News & Events
Artios Announces $153 Million (£110 Million) Series C Financing Led by Omega Funds and TCG X
| Press release
Exciting press coverage following our Polθ (Pol-theta) press release – Nature Communications
| Media coverage
Our press coverage following our Novartis collaboration
| Media coverage
Artios Pharma Publishes Preclinical Data on The First Selective Small Molecule Polθ Polymerase Inhibitor in Nature Communications
| Press release
Artios Pharma Announces Collaboration with Novartis to Create Next Generation DDR Cancer Therapies
| Press release
